Literature DB >> 11996974

Radiation-induced genetic instability in vivo depends on p53 status.

Li Liang1, Changshun Shao, Li Deng, Marc S Mendonca, Peter J Stambrook, Jay A Tischfield.   

Abstract

In response to ionizing radiation and other agents that damage DNA, the p53 tumor suppressor protein activates multiple cellular processes including cell cycle checkpoints and programmed cell death. Although loss of p53 function is associated with radiation-induced genetic instability in cell lines, it is not clear if this relationship exists in vivo. To study the role of p53 in maintenance of genetic stability in normal tissues following irradiation, we have measured mutant frequencies at the adenine phosphoribosyltransferase (Aprt) and hypothanine-guanine phosphoribosyltransferase (Hprt) loci and examined mechanisms of loss of heterozygosity (LOH) in normal T cells of p53-deficient, Aprt heterozygous mice that were subjected to whole-body irradiation with a single dose of 4Gy X-rays. The radiation-induced mutant frequency at both the Aprt and Hprt loci was elevated in cells from mice with different p53 genotypes. The radiation-induced elevation of p53-/- mice was significantly greater than that of p53+/- or p53+/+ mice and was caused by several different kinds of mutational events at the both chromosomal and intragenic levels. Most significantly, interstitial deletion, which occurs rarely in unirradiated mice, became the most common mechanism leading to LOH in irradiated p53 null mice. These observations support the idea that absence or reduction of p53 expression enhances radiation-induced tumorigenesis by increasing genetic instability at various loci, such as those for tumor suppressor genes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11996974     DOI: 10.1016/s0027-5107(02)00029-5

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  9 in total

Review 1.  Genotype phenotype correlation in Li-Fraumeni syndrome kindreds and its implications for management.

Authors:  R N Moule; S G Jhavar; R A Eeles
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

2.  Leiomyosarcomas of the oral cavity: report of a radiation-associated and a metastatic case.

Authors:  Rebeca Souza Azevedo; Fábio Ramôa Pires; Adriele Ferreira Gouvêa; Márcio Ajudarte Lopes; Jacks Jorge
Journal:  Oral Maxillofac Surg       Date:  2011-09-27

3.  Ionizing radiation is a potent inducer of mitotic recombination in mouse embryonic stem cells.

Authors:  Natalia G Denissova; Irina V Tereshchenko; Eric Cui; Peter J Stambrook; Changshun Shao; Jay A Tischfield
Journal:  Mutat Res       Date:  2011-07-23       Impact factor: 2.433

4.  The rate of spontaneous mutations in human myeloid cells.

Authors:  David J Araten; Ondrej Krejci; Kimberly Ditata; Mark Wunderlich; Katie J Sanders; Leah Zamechek; James C Mulloy
Journal:  Mutat Res       Date:  2013-06-06       Impact factor: 2.433

5.  Role of the esophageal vagus neural pathway in ionizing irradiation-induced seizures in nitric oxide synthase-1 homologous recombinant negative NOS1-/- mice.

Authors:  Mark E Bernard; Hyun Kim; Jean-Claude Rwigema; Michael W Epperly; Eric E Kelley; Geoffery H Murdoch; Tracy Dixon; Hong Wang; Joel S Greenberger
Journal:  In Vivo       Date:  2011 Nov-Dec       Impact factor: 2.155

6.  p53 null fluorescent yellow direct repeat (FYDR) mice have normal levels of homologous recombination.

Authors:  Dominika M Wiktor-Brown; Michelle R Sukup-Jackson; Saja A Fakhraldeen; Carrie A Hendricks; Bevin P Engelward
Journal:  DNA Repair (Amst)       Date:  2011-10-12

7.  The spectra of large second-step mutations are similar for two different mouse autosomes.

Authors:  Elizabeth Kasameyer; Lanelle Connolly; Michael Lasarev; Mitchell S Turker
Journal:  Mutat Res       Date:  2007-07-17       Impact factor: 2.433

8.  Mutagenesis in vivo in T cells of p21-deficient mice.

Authors:  Changshun Shao; Li Liang; Xin Zhao; Yanping Chen; Betty Zheng; Jianmin Chen; Minjie Luo; Jay A Tischfield
Journal:  Mutat Res       Date:  2009-09-08       Impact factor: 2.433

9.  Mutagenic assessment of chemotherapy and Smac mimetic drugs in cells with defective DNA damage response pathways.

Authors:  Mark A Miles; Christine J Hawkins
Journal:  Sci Rep       Date:  2018-09-26       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.